HESSEL PHARMA ApS: Financial statements 2012
CVR: 32560903
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
HESSEL PHARMA ApS (CVR 32560903) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 1,154,056 and a net result of DKK 132,920. Equity in the 2012 report amounted to DKK 610,520. The solvency ratio was 73.3%.
- Gross Profit
- DKK 1,154,056
- Profit/Loss
- DKK 132,920
- Equity
- DKK 610,520
- Total Assets
- DKK 832,736
Official annual report
Keep an eye on HESSEL PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout HESSEL PHARMA ApS
HESSEL PHARMA ApS was a Danish company of the type Anpartsselskab based in Stenløse, founded in 2009. The company has been dissolved on 7 December 2020. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company has 0 employees (2013). In 2019, the company reported a gross profit of DKK 3,305,350 and a net result of DKK 2,575,472 compared with DKK 30,406 the year before. Equity in the 2019 report amounted to DKK 635,471.